Evidence map›Paper›PMID 9032400›Full record

ArticleJournal of virology1997

Host-specific driving force in human immunodeficiency virus type 1 evolution in vivo.

L Zhang, R S Diaz, D D Ho, J W Mosley, M P Busch, A Mayer

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00005301 (Transfusion Safety Study), which is not on this map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00005301 completednot on this map

Transfusion Safety Study (TSS)

TypeobservationalSponsorNational Heart, Lung, and Blood Institute (NHLBI)Ran1984 to 1998ConditionsAcquired Immunodeficiency Syndrome, Blood Transfusion, HIV Infections
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

L ZhangAaron Diamond AIDS Research Center, The Rockefeller University, New York, New York 10016, USA. lzhang@adarc.org
R S Diaz
D D Ho
J W Mosley
M P Busch
A Mayer
Aaron Diamond AIDS Research Center · USRockefeller University · US

Funding

SERUM RESPOSITORY FOR HTLV-111 TESTING -AIDSN01HB047002 · HB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MOSLEY, JAMES W · 1985 to 1985
–
BLOOD USE IMMUNE FUNCTION CHANGE RELATION TO AIDSN01HB047003 · HB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MOSLEY, JAMES W · 1985 to 1989
–
TRANSFUSION SAFETY STUDY (TSS) CONTINUATIONN01HB097074 · HB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MOSLEY, JAMES W · 1989 to 1998
–
NHLBI NIH HHS N01-HB-47002NHLBI NIH HHS N01-HB-47003NHLBI NIH HHS N01-HB-97074
6 · The paper itself

Abstract

To investigate the process of human immunodeficiency virus type 1 (HIV-1) evolution in vivo, a total of 179 HIV-1 V3 sequences derived from cell-free plasma were determined from serial samples in three epidemiologically linked individuals (one infected blood donor and two transfusion recipients) over a maximum period of 8 years. A systematic analysis of pairwise comparisons of intrapatient sequences, both within and between each sample time point, revealed a preponderance and accumulation of nonsynonymous rather than synonymous substitutions in the V3 loop and flanking regions as they diverged over time. This strongly argues for the dominant role that positive selection for amino acid change plays in governing the pattern and process of HIV-1 env V3 evolution in vivo and nullifies hypotheses of purely neutral or mutation-driven evolution or completely chance events. In addition, different rates of evolution of HIV-1 were observed in these three different individuals infected with the same viral strain, suggesting that the degree of positive pressure for HIV-1 amino acid change is host dependent. Finally, the observed similar rate of accumulation in divergence within and between infected individuals suggests that the process of genetic divergence in the HIV epidemic proceeds regardless of host-to-host transmission events, i.e., that transmission does not reset the evolutionary clock.

Indexed as

Amino Acid SequenceBase SequenceDNA, ViralEvolution, MolecularHIV-1HIV Envelope Protein gp120HumansMolecular Sequence DataMutagenesisPeptide FragmentsSequence Homology, Amino AcidTime FactorsDNA, ViralHIV Envelope Protein gp120HIV envelope protein gp120 (305-321)Peptide Fragments

Identifiers

PMID9032400
PMCPMC191373
OpenAlexW2164640085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.